Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4
Closed -$2 1272
2021
Q3
$2 Hold
4
﹤0.01% 1239
2021
Q2
$2 Hold
4
﹤0.01% 1231
2021
Q1
$3 Hold
4
﹤0.01% 1181
2020
Q4
$1 Hold
4
﹤0.01% 1155
2020
Q3
$2 Hold
4
﹤0.01% 1102
2020
Q2
$2 Hold
4
﹤0.01% 1068
2020
Q1
$2 Hold
4
﹤0.01% 1046
2019
Q4
$3 Hold
4
﹤0.01% 1052
2019
Q3
$1 Hold
4
﹤0.01% 1056
2019
Q2
$8 Buy
+4
New +$13 ﹤0.01% 1064
2019
Q1
Sell
-4
Closed -$11 1112
2018
Q4
$11 Hold
4
﹤0.01% 1090
2018
Q3
$56 Hold
4
﹤0.01% 1119
2018
Q2
$87 Hold
4
﹤0.01% 1125
2018
Q1
$101 Hold
4
﹤0.01% 1104
2017
Q4
$170 Hold
4
﹤0.01% 1110
2017
Q3
$251 Buy
+4
New +$369 ﹤0.01% 1106

Other funds holding ADXS

RBC Europe's ADXS Position: Q4 2021 in Review

RBC Europe sold out of Advaxis Inc (ADXS) in Q4 2021, closing a stake of 4 shares — an estimated $2 sold.

RBC Europe first reported a position in ADXS in Q3 2017 and held it in 16 quarters. The position peaked at $251 in Q3 2017. 6 funds tracked by Wall St. Rank hold ADXS as of Q4 2021.

  • RBC Europe reported no remaining Advaxis Inc position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 4 Advaxis Inc shares in Q4 2021, an estimated $2.
  • RBC Europe first reported a position in Advaxis Inc in Q3 2017 and held it in 16 quarters.
  • RBC Europe's Advaxis Inc position peaked at $251 in Q3 2017.
  • 6 funds tracked by Wall St. Rank held Advaxis Inc as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.